Currently Viewing:
Supplements New Perspectives on Overactive Bladder: Quality of Life Impact, Medication Persistency, and Treatmen
New Perspectives on Overactive Bladder: Quality of Life Impact, Medication Persistency, and Treatment Costs
C. Daniel Mullins, PhD; and Leslee L. Subak, MD
Persistence With Overactive Bladder Pharmacotherapy in a Medicaid Population
Fadia T. Shaya, PhD, MPH; Steven Blume, MS; Anna Gu, MA; Teresa Zyczynski, PharmD, MBA, MPH; and Zhanna Jumadilova, MD, MBA
The Impact of Urinary Incontinence on Quality of Life of the Elderly
Yu Ko, MS; Swu-Jane Lin, PhD; J. Warren Salmon, PhD; and Morgan S. Bron, PharmD, MS
Safety and Tolerability of Tolterodine for the Treatment of Overactive Bladder in Adults
Richard G. Roberts, MD, JD; Alan D. Garely, MD; and Tamara Bavendam, MD
Medical Costs After Initiation of Drug Treatment for Overactive Bladder: Effects of Selection Bias on Cost Estimates
Nicole M. Nitz, PhD; Zhanna Jumadilova, MD, MBA; Theodore Darkow,   PharmD; Jennifer R. Frytak, PhD; and Tamara Bavendam, MD
Economic Impact of Extended-release Tolterodine versus Immediate-and Extended-release Oxybutynin Among Commercially Insured Persons With Overactive Bladder
Sujata Varadharajan, MS; Zhanna Jumadilova, MD, MBA; Prafulla Girase, MS; and Daniel A. Ollendorf, MPH
Urinary Incontinence in the Nursing Home: Resident Characteristics and Prevalence of Drug Treatment
Zhanna Jumadilova, MD, MBA; Teresa Zyczynski, PharmD, MBA, MPH; Barbara Paul, MD; and Siva Narayanan, MS, MHS
Treatment of Overactive Bladder: A Model Comparing Extended-release Formulations of Tolterodine and Oxybutynin
Eleanor M. Perfetto, PhD; Prasun Subedi, MS; and Zhanna Jumadilova, MD, MBA
Currently Reading
PARTICIPATING FACULTY

PARTICIPATING FACULTY

This supplement to The American Journal of Managed Care includes information on overactive bladder, including costs, treatments, and impact on patients'quality of life.

Faculty
Tamara Bavendam, MD
Director, Team Leader
US Medical, Detrol
Pfizer Inc
New York, New York

Steven Blume, MS
Senior Project Manager
The MEDTAP Institute at UBC
Bethesda, Maryland

Morgan S. Bron, PharmD, MS
Manager, Depression and Anxiety
Disease Management Team
US Outcomes Research
Pfizer Inc
New York, New York

Theodore Darkow, PharmD
Researcher
i3 Magnifi, an Ingenix Company
Health Economics and Outcomes Group
Eden Prairie, Minnesota

Jennifer R. Frytak, PhD
Senior Researcher
i3 Magnifi, an Ingenix Company
Health Economics and Outcomes Group
Eden Prairie, Minnesota

Alan D. Garely, MD
Chief, Gynecology, Department of Obstetrics & Gynecology
Director, Division of Urogynecology and Pelvic
Reconstructive Surgery
Winthrop University Hospital
Mineola, New York

Prafulla Girase, MS
Senior Programmer/Analyst
Pfizer Inc
New York, New York

Anna Gu, MA
Graduate Research Assistant, PhD Student
University of Maryland
School of Pharmacy
Pharmaceutical Health Services
Research Department
Baltimore, Maryland

Zhanna Jumadilova, MD, MBA
Senior Manager
US Outcomes Research
Pfizer Inc
New York, New York

Yu Ko, MS
Doctoral Student and Graduate Associate
Department of Pharmaceutical Sciences
College of Pharmacy
University of Arizona
Tucson, Arizona
Swu-Jane Lin, PhD
Assistant Professor
Department of Pharmacy Administration
College of Pharmacy
University of Illinois at Chicago
Chicago, Illinois

C. Daniel Mullins, PhD
Associate Director
Center for Pharmacoeconomic Research
University of Maryland School of Pharmacy
Baltimore, Maryland

Siva Narayanan, MS, MHS
Director
Outcomes Research, Pharmacy Consulting Group
Beverly Enterprises, Inc
Fort Smith, Arkansas

Nicole M. Nitz, PhD
Researcher
i3 Magnifi, an Ingenix Company
Health Economics and Outcomes Group
Eden Prairie, Minnesota

Daniel A. Ollendorf, MPH
Vice President
Analytic & Consulting Services
PharMetrics, Inc
Watertown, Massachusetts

Barbara Paul, MD
Senior Vice President
Chief Medical Officer
Beverly Enterprises, Inc
Fort Smith, Arkansas

Eleanor M. Perfetto, PhD
Managing Consultant
Epidemiology & Biostatistics
The Weinberg Group Inc
Washington, DC

Richard G. Roberts, MD, JD
Professor
Department ofFamily Medicine
University of Wisconsin Medical School
Madison, Wisconsin

J. Warren Salmon, PhD
Professor of Pharmacy Administration
College of Pharmacy
Professor of Health Policy and Management
School of Public Health
University of Illinois at Chicago
Chicago, Illinois

Fadia T. Shaya, PhD, MPH
Assistant Professor
Associate Director
Center on Drugs and Public Policy
University of Maryland School of Pharmacy
Baltimore, Maryland

Leslee L. Subak, MD
Obstetrician/Gynecologist
Gynecology and Continence Program
University of California
UCSF Women's Health-Mount Zion Campus
San Francisco, California

Prasun Subedi, MS
Pharmaceutical Health Services Research
University of Maryland
School of Pharmacy
Baltimore, Maryland

Sujata Varadharajan, MS
Research Associate
Pfizer Inc
New York, New York

Teresa Zyczynski, PharmD, MBA, MPH
Senior Director
US Outcomes Research
Pfizer Inc
New York, New York

Faculty Disclosure

It is the policy of The American Journal of Managed Care to have all faculty who participate in programs sponsored by pharmaceutical companies disclose any real or apparent conflicts of interest.

These participants report relationships with the following pharmaceutical companies:

  • Alan D. Garely, MD
      Research Support From, Speaker For, Consultant To:
    • IndeVus
    • Pfizer
    • Yamanouchi Pharma
  • Yu Ko, MS
      Research Grant From:
    • Pfizer
  • C. Daniel Mullins, PhD
      Grant Support From/Consultant To:
    • Pfizer
      Consultant and Advisor To:
    • Novartis
  • Siva Narayanan, MS, MHS
      Research Grant From:
    • Pfizer
  • Daniel A. Ollendorf, MPH
      Research Grant From:
    • Pfizer
  • Barbara Paul, MD
      Research Grant From:
    • Pfizer
  • Eleanor M. Perfetto, PhD
      Consultant To:
    • Adventrx
    • Altana
    • Bayer
    • Genzyme
  • Richard Roberts, MD, JD
      Consultant To:
    • Novartis
    • Ortho-McNeil
    • Pfizer
    • Yamanouchi
  • J. Warren Salmon, PhD
      Consultant To:
    • Pharmacia
  • Fadia T. Shaya, PhD, MPH
      Research Grants From:
    • Novartis
    • Pfizer
    • Roche
    • Shire
  • Prasun Subedi, MS
      Subcontractor For:
    • Pfizer

These participants report no relationships with pharmaceutical companies:

  • Prafulla Girase, MS
  • Anna Gu, MA
  • Swu-Jane Lin, PhD
  • Sujata Varadharajan, MS

These participants are employees of Pfizer:

  • Tamara Bavendam, MD
  • Morgan S. Bron, PharmD, MS
  • Zhanna Jumadilova, MD, MBA
  • Teresa Zyczynski, PharmD, MBA, MPH

These participants are employees of i3 Magnifi or MEDTAP Institute at UBC, which perform work funded by a variety of pharmaceutical companies, including Pfizer:

  • Steven Blume, MS
  • Theodore Darkow, PharmD
  • Jennifer R. Frytak, PhD
  • Nicole M. Nitz, PhD

Signed disclosures are on file at the offices of The American Journal of Managed Care, Jamesburg, New Jersey.

This program is being supported by an educational grant from Pfizer.

The contents of this supplement may include information regarding the use of products that may be inconsistent outside the approved labeling for these products in the United States. Physicians should note that the use of these products outside current approved labeling is considered experimental and are advised to consult prescribing information for these products.

PDF
 
Copyright AJMC 2006-2020 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up